Skip to main content
Chemical Solutions for Biological Challenges | csbc2024

Speakers

Professor

Daniel C. Anthony

University of Oxford, UK
Dr

Samuel Genheden

AstraZeneca, Sweden

View bio

Samuel Genheden leads the Deep Chemistry team in Discovery Sciences, AstraZeneca R&D. He received his PhD in theoretical chemistry from Lund University in 2012, having studied computational methods to estimate ligand-binding affinities. He continued with postdocs at the Universities of Southampton and Gothenburg, where he simulated membrane phenomena using multiscale approaches. He joined the Molecular AI department at AstraZeneca in 2020 and became team leader in 2022. The team’s research focuses on the AiZynth platform for AI-assisted retrosynthesis planning. Samuel’s interests lie in studying chemical and biological systems with computers and using these approaches to impact drug development. He is a keen advocate for open-source software.

Professor

Jesús Jiménez-Barbero

Chemical Glycobiology Laboratory, CIC bioGUNE, Spain

View bio

Jesús Jiménez-Barbero is Ikerbasque Research Professor and Scientific Director of CIC bioGUNE since 2014. He received his PhD in 1987. He later spent pre- and post-doc stages (1988-1992) at CERMAV-CNRS; Univ Zurich; National Institute for Medical Research, and Carnegie Mellon. Before moving to CIC bioGUNE where he has led its recognition as Severo Ochoa Center of Excellence in 2017 and 2022, he was CSIC Research Professor at CIB-CSIC (2002-14). Previously, he was CSIC tenured (1992-96) and senior scientist (1996-2002), and Visiting Professor at École Normale Supérieure (2004), Sorbonne (2009), Milano Bicocca (2009-12), and now at the University Basque Country since 2016.

Dr

Mika Jokinen

DelSiTech Oy, Finland

View bio

Mika Jokinen is Chief Scientific Officer of DelSiTech Ltd. He holds a doctoral degree in Chemical Engineering (focus area in the doctoral thesis was development and processing of sol-gel derived bioceramics). He also holds the position of Adjunct Professor (Docent) in Medical Biomaterials in Åbo Akademi University (Turku, Finland) since 2003. He has 30 years of research experience in the development of different types of medical biomaterials in universities and companies. Recently his research has focused on development of long-acting silica-based injectable materials for parenteral controlled delivery of drugs, e.g., small molecules, peptides, proteins, RNA, antisense nucleotides, and vaccine antigens.

Professor

Peter Wipf

University of Pittsburgh, USA

View bio

Peter Wipf received his Ph.D. in Chemistry from the University of Zürich. He joined the laboratory of Prof. R. E. Ireland at the University of Virginia as a Swiss NSF postdoctoral fellow, and, in 1990, he moved to the University of Pittsburgh, where he holds the rank of Distinguished University Professor and co-Leader of the Cancer Therapeutics Program. He is currently also a visiting Professor at UEF in Kuopio. His group works in natural products total synthesis and also pursues a diverse range of projects in medicinal and heterocyclic chemistry. He has co-authored over 700 journal articles, books and patents.